Based on these findings, we have demonstrated that CrF‐EVs have significant beneficial roles in improving lymphatic functions and alleviating colitis and mesenteritis via the miR‐132‐3p/RASA1/ERK1/2 axis. This evidence concerns the gene RASA1 and colitis.